Share this article
Share this article
BUENA, N.J., Feb. 23, 2021 /PRNewswire/ Teligent, Inc. (Nasdaq: TLGT), ( Teligent or the Company ), a New Jersey-based specialty generic pharmaceutical company, today announced it has appointed Carter Pate to its Board of Directors, effective immediately. Mr. Pate will serve on the Audit and Nominating and Corporate Governance Committees.
Mr. Pate leads a family-owned investment firm and serves on the Board of Directors at multiple companies, including Global Step and Advanced Emissions Solutions, Inc. He excels at leading companies through moments of change to drive business objectives and redefine their possibilities for growth.
John Celentano, Chairman of Teligent s Board of Directors, commented on the appointment, stating, We are excited to have Carter join Teligent s Board. Carter s years of experience have given him an abundance of knowledge of various industries, and he has proven that he can help shepherd businesses throug
Share this article
Share this article
BUENA, N.J., Feb. 16, 2021 /PRNewswire/ Teligent, Inc. (Nasdaq: TLGT), ( Teligent or the Company ), a New Jersey-based specialty generic pharmaceutical company, today announced it has appointed industry veteran William S. Marth to its Board of Directors, effective immediately. Mr. Marth brings over 25 years of expertise and a proven track record of leading companies in the generic pharmaceutical and contract manufacturing industries.
John Celentano, Chairman of Teligent s Board of Directors, commented on the appointment, stating that We are excited to have Bill join Teligent s Board of Directors. He is a strategic leader with extensive experience in helping businesses transform and achieve their potential. Following the strategic steps we announced earlier this year to strengthen the Company s balance sheet and position the business for success, we have reached a critical time in Teligent s journey where Bill s innovative thinking will b